Exact Sciences Corp (EXAS.OQ)
EXAS.OQ on NASDAQ Stock Exchange Capital Market
46.93USD
24 Apr 2018
46.93USD
24 Apr 2018
Change (% chg)
-- (--)
-- (--)
Prev Close
$46.93
$46.93
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
799,566
799,566
52-wk High
$63.60
$63.60
52-wk Low
$23.71
$23.71
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- ownership
- filings
- deals
- private equity
- third-party document and information retrieval
- estimates
- fundamentals
- economics
- events
- news
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
Name | Age | Since | Current Position |
---|---|---|---|
Kevin Conroy |
51 | 2014 | Chairman of the Board, President, Chief Executive Officer |
Jeffrey Elliott |
39 | 2016 | Chief Financial Officer |
Maneesh Arora |
48 | 2013 | Chief Operating Officer, Senior Vice President, Director |
Graham Lidgard |
68 | 2009 | Senior Vice President, Chief Scientific Officer |
D. Scott Coward |
52 | 2015 | Senior Vice President, General Counsel, Secretary |
- BRIEF-Mark Stenhouse To Join Exact Sciences As President, Cologuard
- BRIEF-Exact Sciences Q4 Loss Per Share $0.18
- BRIEF-Exact Sciences announces upsize, pricing of $600 mln of 1 pct convertible senior notes due 2025
- BRIEF-Exact Sciences Offers $500 Mln Convertible Senior Notes Due 2025
- BRIEF-Exact Sciences Says "Comfortable" With Current 2018 Consensus Revenue Estimate Of Around $417 Mln